Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
19 2월 2025 - 7:48AM
Edgar (US Regulatory)
Exhibit 99.3
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii)
under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of
a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Shares, without par value, of Edesa Biotech,
Inc., a British Columbia corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Velan Capital Master Fund LP |
|
By: |
/s/ Adam Morgan |
|
|
Adam Morgan, Managing Member of Velan Capital Holdings LLC, its General Partner |
Date: |
02/18/2025 |
Velan Horizon Fund LP |
|
By: |
/s/ Adam Morgan |
|
|
Adam Morgan, Managing Member of Velan Horizon GP LLC, its General Partner |
Date: |
02/18/2025 |
Velan Capital Opportunity Fund II LLC |
|
By: |
/s/ Adam Morgan |
|
|
Adam Morgan, Managing Member of Velan Capital Holdings LLC, its Managing Member |
Velan Horizon GP LLC |
|
By: |
/s/ Adam Morgan |
|
|
Adam Morgan, Managing Member |
Date: |
02/18/2025 |
Velan Capital Holdings LLC |
|
By: |
/s/ Adam Morgan |
|
|
Adam Morgan, Managing Member |
Date: |
02/18/2025 |
Velan Capital Investment Management LP |
|
By: |
/s/ Adam Morgan |
|
|
Adam Morgan, Managing Member of Velan Capital Management LLC, its General Partner |
Date: |
02/18/2025 |
Velan Capital Management LLC |
|
By: |
/s/ Adam Morgan |
|
|
Adam Morgan, Managing Member |
Date: |
02/18/2025 |
Morgan Adam |
|
By: |
/s/ Adam Morgan |
|
|
Adam Morgan |
Date: |
02/18/2025 |
VENKATARAMAN BALAJI |
|
By: |
/s/ Balaji Venkataraman |
|
|
Balaji Venkataraman |
Date: |
02/18/2025 |
Edesa Biotech (NASDAQ:EDSA)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Edesa Biotech (NASDAQ:EDSA)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025